Advertisement

Topics

Immunomic Therapeutics adds John H. Sampson to scientific advisory board

09:07 EDT 1 Aug 2017 | CentreWatch

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome a new oncology advisor, Duke University’s John H. Sampson, M.D., Ph.D., to the Immunomic scientific advisory board as the company pursues application of the investigational LAMP-Vax platform technology in oncology. Dr. Sampson will advise on scientific and technical matters relating to brain […]

The post Immunomic Therapeutics adds John H. Sampson to scientific advisory board appeared first on CenterWatch News Online.

Original Article: Immunomic Therapeutics adds John H. Sampson to scientific advisory board

NEXT ARTICLE

More From BioPortfolio on "Immunomic Therapeutics adds John H. Sampson to scientific advisory board"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...